Johnson & Johnson (NYSE:JNJ)

107.18
Real-Time Quote
 +0.99 / +0.93%
Today’s Change
85.50
Today|||52-Week Range
107.20
+17.02%
Year-to-Date
Gilead Sciences, inc. Stock's Incoming Game Changer
8:46am / MotleyFool.com
Apple or Exxon: Which is a better buy?
Sep 08 / CNNMoney.com
Corporate bond ratings do not discern risk
4:17am / FT.com
Stryker Grows via Acquisitions but M&A Deals Pose Risk - Analyst Blog
Sep 05 / Zacks.com
New Active ETF for All Risk Environments
Sep 17 / Benzinga
Dow 30 Stock Roundup: MSFT Widens Surface Pro 3 Availability, MCD Shutters Several Ru...
Sep 05 / Zacks.com
Why It's Time for Allergan Shareholders to Take Some Profits
Sep 16 / TheStreet.com
Volunteers sought for human trials of Ebola vaccine
Sep 05 / FT.com
AstraZeneca and Eli Lilly to unite for Alzheimer's drug challenge
Sep 16 / FT.com
3 Reasons Bristol-Myers Squibb's Stock Could Fall
Sep 04 / MotleyFool.com
3 Stocks Reiterated As A Buy: MA, NTAP, JNJ
Sep 15 / TheStreet.com
J&J Ebola Vaccine Gets Funding, Development to Pick Pace - Analyst Blog
Sep 04 / Zacks.com
Dow Jones (DJIA) Today: Johnson & Johnson (JNJ) Leads The Day Higher, Exxon Mobil Cor...
Sep 12 / TheStreet.com
CONMED Benefits from Minimally Invasive Surgery Trends - Analyst Blog
Sep 04 / Zacks.com
Trading Guidelines for J&J, Merck, Pfizer, 8 Other Drug Companies
Sep 12 / TheStreet.com
Bristol-Myers Squibb's Eliquis Takes Aim at Johnson & Johnson
Sep 04 / MotleyFool.com
Insider Trading Alert - JNJ, EL And GPI Traded By Insiders
Sep 12 / TheStreet.com
3 Reasons Gilead Sciences, Inc.bs Stock Could Fall
Sep 04 / MotleyFool.com
Blue Chip Stocks: Investing Essentials
Sep 11 / MotleyFool.com
Heed L.L. Bean as swans gather
Sep 03 / FT.com
Medivation Inc's FDA Approval Could be the Deathblow for Johnson & Johnson's Blockbus...
Sep 10 / MotleyFool.com
The U.S. dollar is super strong now
Sep 02 / CNNMoney.com
A Top Dividend Stock for Your Portfolio: Johnson & Johnson
Sep 10 / MotleyFool.com
7 companies that keep more than $50 billion offshore
Aug 27 / CNNMoney.com
Glaxo Announces EU Nod for Single-Pill HIV Drug Triumeq - Analyst Blog
Sep 08 / Zacks.com
Chinese pharma R&D marks step forward
Aug 26 / FT.com
Ebola Outbreak Strikes Africa: How We're Fighting Back
Sep 08 / MotleyFool.com
The Longer Term View On Johnson & Johnson
Aug 25 / StockTwits
3 Reasons Medtronic Inc. Stock Could Rise
Sep 08 / MotleyFool.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.